LDS/Medical Tests/Group B Streptococcus (GBS), Molecular Detection, PCR

Group B Streptococcus (GBS), Molecular Detection, PCR

The organism Streptococcus agalactiae, commonly known as Group B strep (GBS), is the leading cause of infant morbidity and mortality in infants younger than 3 months in the US. GBS is considered a normal inhabitant of the female genital tract and a large percentage of healthy women harbor this organism. For non-pregnant women, colonization with GBS poses no significant harm. Pregnant women who harbor GBS, however, can pass it to their infants during childbirth, resulting in severe neonatal GBS disease. In infants, GBS causes septicemia, meningitis, and pneumonia, all of which may be fatal. Cellulitis, osteomyelitis, and septic arthritis are also common clinical manifestations. Although extremely rare, GBS may also cause pregnancy-associated morbidity in the mother. Urinary tract infections due to GBS are found in 2% - 4% of pregnant females. These infections are generally mild and often go unnoticed, but may be a source of infection for the infant. Other pregnancy-related infections include sepsis, amnionitis, endometritis, endocarditis, and rarely, meningitis.

In an attempt to eliminate early-onset GBS disease, several clinical studies were performed that clearly showed that early identification and treatment of GBS in pregnant women decreased transmission of the organism to the infant. As a result of these studies, several agencies developed guidelines for the identification of GBS in pregnant women. In 2002, the US Centers for Disease Control and Prevention (CDC) updated these guidelines to include screening all pregnant women at 35 - 37 weeks gestation and giving antibiotic treatment to patients that are shown to be colonized with GBS.

The most common method for the identification of GBS is with culture; however, cultures can typically take up to 48 hours for a result. Molecular methods such as real-time PCR assay greatly speed up the testing process and can provide a result in a matter of hours. This is significant, particularly for women requiring screening at the time of delivery (those delivering prior to 35 -37 weeks). In addition, molecular methods have demonstrated significant sensitivity and specificity for detection of GBS from vaginal rectal swabs.

  • Screening for Group B strep colonization in pregnant women
  • Diagnosis of neonatal meningitis
  • As an aid in diagnosis of group B streptococcus infection

Positive in:

  • Pregnant women colonized with Group B strep
  • Neonatal meningitis due to Group B Strep
  • Group B strep infection
  • Urine tract infection in pregnant women due to Group B Strep
  • Urine tract infection in catheterized patient due to Group B Strep

Negative (Not Detected)
 

 

Real-time polymerase chain reaction (PCR) Transcription medicate amplification (TMA), other molecular methods. 

Vaginal and/or Rectal swab collected and transported in culture transport media. 

Stability

  • Ambient: 1-3 days
  • Refrigerated: 5-7 days

Susceptibility Testing, Chlamydia and Gonorrhea DNA, Genital Culture, Group B Strep culture, HSV by PCR, Ureaplasma urealiticum, Mycoplasma homini, Trichomonas vaginalis, Yeast culture, Genital culture for other vaginosis and vaginitis infections.

Usually same day.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Am J Obstet Gynecol. 2011 Oct;205(4):372.e1-6. [PMID: 21864820]
  • MMWR Recomm Rep. 2010 Nov 19;59(RR-10):1-36. [PMID: 21088663]
  • Clin Perinatol. 2010 Jun;37(2):375-92. [PMID: 20569813]
  • MMWR Recomm Rep. 2002 Aug 16;51(RR-11):1-22. [PMID: 12211284]
  • Ann Rev Med. 1977; 28: 355-369. [PMID: 324367]
  • Forbes BA, Sahm DF, and Weissfeld AS (eds). Bailey and Scott’s Diagnostic Microbiology, 11th ed. p.927-938 (2002).
  • Mandell GL and Bennett JE. Mandell and Bennett's Principles and Practices of Infectious Diseases, 4th ed. New York: Churchill Livingstone (1995).